Navigation Links
Amylin Pharmaceuticals to Webcast Conference Call
Date:10/31/2007

SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast a conference call on Wednesday, October 31, 2007 at 8:30 a.m. ET/5:30 a.m. PT to discuss today's release of the once-weekly exenatide long-acting release study results. Daniel M. Bradbury, Amylin's President and Chief Executive Officer, will lead the call.

The call will be webcast live through Amylin's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to http://www.amylin.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (866) 356-3095 (domestic) or (617) 597-5391 (international), passcode 19644079. A replay of the call will also be available by phone for 24 hours beginning approximately one hour after the close of the call and can be accessed at (888) 286-8010 (domestic) or (617) 801-6888 (international), passcode 23209035.

About Amylin Pharmaceuticals, Inc.

Amylin Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California with over 1,800 employees natio
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...study found they spurred blood vessel growth after...Day News) -- Adult stem cells appear to help repai... phase 1 study of 53 patients found that stem cell...w blood vessels in heart tissue damaged by heart a...jections within 10 days of having a heart attack. ...
(Date:12/4/2009)... , MADISON, Wis., Dec. 4 /PRNewswire-FirstCal... fall, the Wisconsin Department of Health Services...e quickly than ever before. Join Sonic Foundry, I...r for rich media webcasting and knowledge manageme...e Wisconsin Department of Health Services, will sh...
(Date:12/4/2009)... , BOULDER, Colo., Dec. 4 ..., ON LOVE ,, Kathryn Budig, a prominent yoga te...e to healing--with a viewing of Twilight,s New Moo...nal.com: ,, http://www.elephantjournal.com/200...ournal.com: TASHI KING AND BREAST CANCER ,, el...
(Date:12/4/2009)... , FORT MYERS, Fla., Dec. 4 /PRNewswire-F...rd: NGNM) announced today that Steven C. Jones h...e and that George A. Cardoza has joined the compan... responsible for managing all internal financial a... will focus on developing strategic initiatives on...
(Date:12/4/2009)... , KINGFISHER, Okla., Dec. 4 ...ppardauctions.com ) announces the public auction o...ng to Troy Lippard, auctioneer. ,, "Kingfisher ... the South end of town," explained Lippard. "There...ute public auction which means it sells to the hig...
Breaking Medicine News(10 mins):Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3Health News:NeoGenomics Announces Executive Appointments 2Health News:Former Kingfisher Regional Hospital Property and Equipment to Sell at Absolute Public Auction 2
... MyCoupons, LLC has furthered its,movement in hel...ancer,research. With the recent release of its Cou...barked on a program that is creating a buzz among ...ir site,with thousands of online retail stores. Ho...
...TON-SALEM, N.C., Oct. 9 Castle,Connolly Medical L...DrScore.com to bring valuable new quality informat... sites, http://www.CastleConnolly.com and, http:...hysicians they have been to as patients, as well a...
...llaboration is important for many clinical trials ...eatments for rare diseases. That was the message d...uncils (EMRC), the membership organisation for med...nd about to launch a review of how best to impleme...
..., a system suggested by some British scholars more... has established the M-POSSUM evaluation system wi...ness of the original system. , Numerous scoring s...he Physiological and Operative Severity Score for ...
...dical Simulation Corporation (MSC) is,proud to ann...akey Heart,Center in Houston to provide simulated ...thodist cardiologists and surgeons improve patient...is simulation technology to practice coronary, car...
... The U.S. Government,through the U.S. Agency for ...irst five organizations to receive grants under th...ations will receive a total of,nearly $7 million t...nder age five and women who are pregnant. The,orga...
Other Medicine News:Health News:MyCoupons, LLC Enlists Clients into the Fight Against Breast Cancer 2Health News:Castle Connolly Medical Ltd. Partners with DrScore.com to Provide Additional Quality Information About Doctors to Consumers 2Health News:Paving the way for future pan-European clinical trials 2Health News:Paving the way for future pan-European clinical trials 3Health News:M-POSSUM, an effective risk assessment system prior to operation 2Health News:Medical Simulation Corporation Announces Partnership with Methodist DeBakey Heart Center in Houston 2Health News:USAID Announces First Malaria Communities Program Grants 2
(Date:12/4/2009)..., , RARITAN, N.J., Dec. 4 /PRNewswire/ -...Attention Deficit Hyperactivity Disorder (ADHD), s...morbidities reported to occur more often in people...rsus those without an epilepsy diagnosis, accordin...across the U.S. ,, Findings from " CNS-Related ...
(Date:12/3/2009)..., , SUNNYVALE, Calif., Dec. 3 /PRNewswi...C ), a biopharmaceutical company focused on develo... drugs for the treatment of immune mediated diseas... webcast and conference call on, Tuesday, December...Time and 8:00am Pacific Time) to discuss clinical ...
(Date:12/3/2009)..., , HOERSHOLM, Denmark and S...,, - SPC3649 Successfully Inhibits miR-122,...ation, Thereby Significantly Reducing Hepatitis C,...y Infected With the,Hepatitis C Virus , -... Viral Resistance and,No Serious Adverse Events in...
Breaking Medicine Technology:Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Computers aid in cracking deception in plants 9002 1Computers aid in cracking deception in plants 9002 2UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 50065 1UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 50065 2UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 50065 3Parents Day is Coming Kidz Med Celebrates the Role of Parents 50061 1Parents Day is Coming Kidz Med Celebrates the Role of Parents 50061 2
... stress-related TMJ problems and create healthy, p... Feldenkrais Movement Institute announces the rele...part of its The Intelligent Body(R) DIY-series... The program offers sufferers of jaw pain an inexp...ce chronic tension in the jaw, face, neck and uppe...
... New Alliance a Key Step for OBT to Broaden its Ex...ford BioTherapeutics (OBT) today announced a strat...velop and commercialise novel, therapeutic,antibod...ecurring forms of,cancer. , Under the alliance...t,selected OBT targets. In parallel OBT will devel...
Other Medicine Technology:Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ) 2Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ) 3Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies 2Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies 3
Girard Tying Forceps - Straight
Trouan Tying Forceps
Hartmann Mosquito Forceps
Mosquito Hartman Forceps
Medicine Products: